Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physalis angulata cream after intense pulsed light for solar melanosis of the hands
RBR-49q54wgPhase 1Completed
- Sponsor
- Universidade Paranaense
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of physalis angulata extract and hydrocortisone in melanosis (2 arms), sponsored by Universidade Paranaense. Started Jul 2019; status: completed.
02
Drugs
physalis angulata extracthydrocortisone
03
Conditions
melanosis
Beyond the preview
Go deeper on RBR-49q54wg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-49q54wg.